Read the docs
TI-2019-07014 Aliases CVE-2019-9596GHSA-667w-x292-xmxh

Darktrace Enterprise Immune System before 3.1 allows CSRF via the /whitelisteddomains endpoint.

Priority LOW 32CWE-352Published · Updated

Key facts

Attack vector
Network
Privileges required
None
User interaction
Required
Attack complexity
Low
Impact type
Tampering
Confidentiality · integrity · availability
None · High · None
Fix status
No fix listed

Attack profile from CVSS 3.1 · NVD. Fix status from CNA. Impact type from CWE-352.

Summary

Darktrace Enterprise Immune System before 3.1 allows CSRF via the /whitelisteddomains endpoint.

Why it matters now

EPSS 0.0162 76th percentileScored 2026-11-07
Public exploit Yes 4 exploit referencesTagged by NVD
Fix No fix listed No fixed version in the sources yet

SSVC decision points

Not available: CISA has not published SSVC decision points for this record.

Affected products

VendorProductAffected versionsFixed inStatusSource
——all versions—No fix listedCNA
  • — Vendor— Affected all versions Fixed in — No fix listed CNA

CPE configurations NVD · 1

CPEVersionsRoleVendor
cpe:2.3:a:darktrace:enterprise_immune_system:*:*:*:*:*:*:*:*before 3.1VulnerableDarktrace
  • cpe:2.3:a:darktrace:enterprise_immune_system:*:*:*:*:*:*:*:* Versions before 3.1 Vulnerable ·Darktrace

Remediation

No fixed version listed by the sources yet.

Timeline

  1. 2026-10-02 Threatist record created from CVE-2019-9596
  2. 2026-10-03 Alias added: GHSA-667w-x292-xmxh

References

Exploit 4

  • TI-2019-07015 Darktrace Enterprise Immune System before 3.1 allows CSRF via the /config endpoint. CVSS 3.1MEDIUM 6.5

Sources

This product uses the NVD API but is not endorsed or certified by the NVD. Sources and licences